The FDA approved a new drug from Eli Lilly, which will be sold under the brand name Kisunla, that has shown to modestly slow a decline in memory loss and thinking abilities for people with Alzheimer’s disease. Dr. Tara Narula joins TODAY with what to know about the medication.
